Position in NBIX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$403,199,491
+$263,523,747 QoQ
Shares Held
3,060,570
+210.8% QoQ
Ownership
3.04%
of shares outstanding
% of Portfolio
0.37%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
19 quarters on record
Voting authority
Sole 97.90235152275557.ToString("F0")%
Shared 0.ToString("F0")%
None 2.0976484772444346.ToString("F0")%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026TWO SIGMA INVESTMENTS, LP holds $750,878,580 across 46 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (53.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
This page
|
3,060,570 | $403,199,491 | |
| 2 | BCRX |
Biocryst Pharmaceuticals Inc
|
6,392,628 | $60,857,818 | |
| 3 | ALKS |
Alkermes plc.
|
780,683 | $27,604,950 | |
| 4 | ESPR |
Esperion Therapeutics, Inc.
|
9,458,779 | $25,917,054 | |
| 5 | LQDA |
Liquidia Corp
|
563,233 | $21,256,413 | |
| 6 | IRWD |
Ironwood Pharmaceuticals Inc
|
5,848,276 | $20,527,448 | |
| 7 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
420,914 | $20,267,009 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
590,116 | $19,515,136 |
All Filings in NBIX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $403,199,491 | 3,060,570 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $139,675,744 | 984,811 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $48,791,174 | 347,565 | Shares | Sole | 2025-11-14 | |
| 2025-03-31 | $1,128,341 | 10,202 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $3,654,241 | 26,771 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $10,373,026 | 90,028 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $18,624,272 | 135,282 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $21,761,017 | 157,780 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $29,633,746 | 224,907 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $5,670,900 | 50,408 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $22,423,219 | 237,786 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $37,459,295 | 370,078 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $68,202,748 | 571,021 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $39,172,372 | 368,820 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,306,864 | 23,665 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $34,365,281 | 366,563 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $14,233,184 | 167,115 | Shares | Sole | 2022-02-14 | |
| 2020-06-30 | $16,957,024 | 138,992 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $26,988,713 | 311,828 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||